Delivery Order SPE2DB20D9223-SPE2DB21FV82A
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,335.76, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a biologic medication. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,182.08 fixed-price contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialized pharmaceutical product, with a period of performance through January 30, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,774.78 contract is for the delivery of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. The contract is not associated with a specific set-aside designation, which allows DMS Pharmaceutical Group...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,144.80 firm fixed-price contract is for the delivery of 4555870895 - ACTEMRA 400 MG/20 ML VIAL 20ML to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,223.84 contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialized pharmaceutical product. The delivery order was issued under a $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to procure...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,923.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with an ultimate completion date of April 25, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, valued at up to $4,999,999 and held by DMS...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,846.72, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a biologic medication. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,759.56, is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,770.08 firm fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,385.04 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of 4564299269 - Actemra Actpen 162 mg/0.9 ml 0.9ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB24FYW67) between DMS Pharmaceutical Group and DLA, valued at up to...
- SPE2DB20D9223Indefinite Delivery Contract
- SPE2DB20D9223-SPE2DB21FV82ADelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,884.92 contract is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This specific delivery order is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across various medical product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 9/27/21 |